Capital Guardian Trust Company »

Neurocrine Biosciences shares owned by Capital Guardian Trust Company

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Capital Guardian Trust Company from 13F filings

Historical chart of Capital Guardian Trust Company investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Capital Guardian Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Capital Guardian Trust Company

Quarter filed Position value Share count Share price at filing
2019-06-30 $46M 547k 84.42
2019-03-31 $47M 537k 88.10
2018-12-31 $35M 496k 71.41

More positions owned by Capital Guardian Trust Company

Enbridge Common Stock (ENB)
Taiwan Semiconductor Mfg Common Stock (TSM)
Asml Holding Nv Common Stock (ASML)
Microsoft Corp Common Stock (MSFT)
Visa Inc Cl A Common Stock (V)
Hdfc Bank Common Stock (HDB)
Facebook Inc Cl A Common Stock (META)
Broadcom Common Stock (AVGO)
Vale Sa On Common Stock (VALE)
Charter Communications Inc Cl A Common Stock (CHTR)
Aon Plc Cl A Common Stock
Ctrip.com Intl Common Stock
Amazon.com Common Stock (AMZN)
Alibaba Group Holding Common Stock (BABA)
Godaddy Inc Cl A Common Stock (GDDY)

View all positions for Capital Guardian Trust Company

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group
DSM Capital Partners
Brown Advisory Holdings Incorporated

View all funds holding Neurocrine Biosciences